Displaying 25 - 36 of 47
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Cirrhosis & Complications
6

Grifols: The journey of a cirrhotic patient: when Albumin plays a key role - ILC 2022

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Liver Tumours
5

Bayer: Addressing a Changing Treatment Dynamic in HCC:  Defining Use of TKIs in Selected Patient Populations - Digital Liver Cancer Summit 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Cirrhosis & Complications
5

Grifols: Management of decompensated cirrhotic patient: is it time to look beyond? - ILC 2021

View
Displaying 25 - 36 of 47